New Nicotine Alliance welcomes smoking and health action report

Sep.02.2022
New Nicotine Alliance welcomes smoking and health action report
New Nicotine Alliance welcomes report on smoking and health actions, highlighting evidence on youth e-cigarette use and dispelling myths.

The New Nicotine Alliance has welcomed the new Smoking and Health Action Plan briefing, stating that it directly addresses the issue of youth vaping. The briefing was released last week and the New Nicotine Alliance referred to it as "a timely document, given the constant media attention on the topic in recent weeks.


The New Nicotine Alliance has announced that its briefing on smoking and health has been endorsed by several public health organizations. The briefing objectively reviews current regulations and the latest evidence from surveys on youth e-cigarette use.


The most important aspect is that it exposes many of the myths recently seen in the media, which have negatively distorted public perception of electronic cigarette products. The New Nicotine Alliance further added that "the UK is globally leading in recognizing the benefits of reduced-risk products like e-cigarettes in helping smokers quit, and we are pleased that ASH has responded to recent negative news with calm and balanced evidenced-based arguments.


A disposable e-cigarette contains less nicotine than a pack of 20 cigarettes. In comparison, a standard 2ml disposable e-cigarette in the UK contains 40mg of nicotine, whereas the average pack of 20 cigarettes contains 250mg of nicotine.


Most young people who try vaping are unlikely to become addicted to nicotine. Vapers are much less likely to develop dependence compared to smokers.


Electronic cigarettes have been on sale in the UK for 15 years, and have been the most popular smoking cessation aid since 2013. During this time, there has been no association between electronic cigarettes and the prevalent health issues in the UK.


In 2019, a severe respiratory illness outbreak (known as "EVALI") in the United States was determined to be caused by vaping marijuana laced with vitamin E acetate, not by nicotine inhalation.


The New Nicotine Alliance continued to state that "ASH emphasized how anti-vaping campaigns have distorted the truth in the minds of the public, contrasting this with the clear information provided in New Zealand versus the destructive approach taken in the US, which has led some young people to conclude that they'd rather smoke than switch to vaping. While it's regrettable that irresponsible media coverage should make such truth-telling necessary, we warmly welcome ASH's intervention and hope that local authorities and other organizations take note of this. In many other countries, moral panic about youth vaping has led to an erosion of controls over nicotine products, such that the benefits that smokers derive from switching to vaping have been entirely diminished or eradicated by restrictions and bans.


The New Nicotine Alliance continued to state, "We are pleased to see that the UK's public health organization has responded to clarify the facts with common sense and rationality, and to support the world's leading UK regulatory body in acknowledging that electronic cigarettes are an important means of helping smokers quit or significantly reducing their harm.


Statement


This article was compiled from third-party information and is intended for industry exchange and learning purposes only.


This article does not represent the views of 2FIRSTS and 2FIRSTS cannot confirm the authenticity and accuracy of the content of the article. The translation of this article is only for industry communication and research purposes.


Due to limitations in translation ability, this article may not fully reflect the original content. Please refer to the original text for accuracy.


2FIRSTS holds the same stance and position as the Chinese government on any domestic, Hong Kong, Macau, Taiwan, and foreign-related issues.


The compilation of information is owned by the original media source and author. If there is any infringement, please contact us for removal.


This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.